C5AR1 and hepatocellular carcinoma: In our previous study, we demonstrated that the S component of Panton-Valentine leucocidin (LukS-PV) can effectively inhibit the progression of hepatocellular carcinoma cells with a higher expression of C5aR, revealing that C5aR may be an important target for cancer therapy [31].